Dr Cole Seifert, PhDResearch Manager at Croda PharmaSpeaker
Profile
Dr. Cole Seifert obtained his PhD in Chemistry from Texas Tech University in 2017. During his PhD research, Dr. Seifert invented Group-Assisted Purification Peptide Synthesis (GAP-PS) Technology. He founded GAP Peptides, a startup to commercialize GAP-PS and served as its President and CSO from 2017 – 2022, followed by acquisition of GAP Technology by Croda, Inc. in 2022. He is the inventor on several pending and issued patents and has led the development through commercial scale of multiple peptide products at Croda.
Agenda Sessions
Optimising GAP Peptide Synthesis for Tirzepatide Fragments
, 10:05View Session

